Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
In terms of the primary outcome of reduction in A1C from baseline, although the 3-mg oral semaglutide group did not demonstrate superiority to sitagliptin 100 mg at 26 weeks, the 7-mg and 14-mg dosage groups did demonstrate statistically significant reductions in A1C from baseline when compared with sitagliptin
Research-use notice For laboratory research use only
The clinician will evaluate your situation and suggest the best protocol to follow
For this study, researchers analyzed U.S
US$ 24.17
US$ 28.24
.png.jpg)
US$ 29.54
